Assay ID | Title | Year | Journal | Article |
AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1161713 | Inhibition of [3H]-DA uptake in human dopamine transporter expressed in HEK293 cells by scintillation counting | 2014 | European journal of medicinal chemistry, Oct-30, Volume: 86 | Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors. |
AID343841 | Inhibition of dopamine uptake at cloned DAT in rat brain synaptosome | 2008 | Bioorganic & medicinal chemistry letters, Jul-01, Volume: 18, Issue:13
| Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors. |
AID343842 | Inhibition of norepinephrine uptake at human cloned NET | 2008 | Bioorganic & medicinal chemistry letters, Jul-01, Volume: 18, Issue:13
| Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors. |
AID491805 | Displacement of [N-methyl-3H]citalopram from human recombinant SERT expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting | 2010 | Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
| 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. |
AID1161711 | Inhibition of [3H]-serotonin uptake in human SERT expressed in HEK293 cells by scintillation counting | 2014 | European journal of medicinal chemistry, Oct-30, Volume: 86 | Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors. |
AID491800 | Displacement of [N-methyl-3H]WIN-35428 from human recombinant DAT expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting | 2010 | Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
| 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. |
AID462683 | Displacement of [3H]citalopram from human recombinant SERT expressed in BacMam virus-transduced cells by scintillation proximity assay | 2010 | Journal of medicinal chemistry, Mar-25, Volume: 53, Issue:6
| 1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors. |
AID1161712 | Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting | 2014 | European journal of medicinal chemistry, Oct-30, Volume: 86 | Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors. |
AID343843 | Inhibition of serotonin uptake at human cloned SERT | 2008 | Bioorganic & medicinal chemistry letters, Jul-01, Volume: 18, Issue:13
| Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors. |
AID462681 | Displacement of [3H]WIN-35428 from human recombinant DAT expressed in BacMam virus-transduced cells by scintillation proximity assay | 2010 | Journal of medicinal chemistry, Mar-25, Volume: 53, Issue:6
| 1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors. |
AID343840 | Inhibition of serotonin uptake at SERT in rat brain synaptosome | 2008 | Bioorganic & medicinal chemistry letters, Jul-01, Volume: 18, Issue:13
| Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors. |
AID343844 | Inhibition of dopamine uptake at human cloned DAT | 2008 | Bioorganic & medicinal chemistry letters, Jul-01, Volume: 18, Issue:13
| Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors. |
AID491801 | Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting | 2010 | Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
| 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. |
AID343839 | Inhibition of norepinephrine uptake at NET in rat brain synaptosome | 2008 | Bioorganic & medicinal chemistry letters, Jul-01, Volume: 18, Issue:13
| Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors. |
AID462682 | Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay | 2010 | Journal of medicinal chemistry, Mar-25, Volume: 53, Issue:6
| 1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |